Beyond Air (NASDAQ:XAIR) Rating Increased to Sell at Wall Street Zen

Beyond Air (NASDAQ:XAIR) was upgraded by equities research analysts at Wall Street Zen to a “sell” rating in a report issued on Friday.

Other equities analysts have also recently issued reports about the company. D Boral Capital raised Beyond Air to a “strong-buy” rating in a research note on Thursday. D. Boral Capital started coverage on Beyond Air in a research note on Thursday. They issued a “buy” rating and a $11.00 price target on the stock. One investment analyst has rated the stock with a sell rating, three have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $23.67.

Beyond Air Price Performance

XAIR opened at $3.26 on Friday. The company has a debt-to-equity ratio of 0.64, a quick ratio of 2.72 and a current ratio of 3.20. Beyond Air has a 52-week low of $2.90 and a 52-week high of $13.52. The stock has a market capitalization of $14.08 million, a PE ratio of -0.21 and a beta of 0.22. The stock’s 50 day moving average price is $3.73 and its 200-day moving average price is $5.25.

Beyond Air (NASDAQ:XAIR) last posted its earnings results on Tuesday, June 17th. The company reported ($1.80) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.80) by $1.00. Beyond Air had a negative return on equity of 233.96% and a negative net margin of 1,258.46%. The firm had revenue of $1.15 million for the quarter, compared to analysts’ expectations of $1.39 million. On average, equities research analysts predict that Beyond Air will post -0.79 EPS for the current year.

Institutional Investors Weigh In On Beyond Air

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Alyeska Investment Group L.P. purchased a new stake in Beyond Air in the fourth quarter worth $2,560,000. Balyasny Asset Management L.P. bought a new stake in Beyond Air in the fourth quarter worth $1,195,000. Kingdon Capital Management L.L.C. boosted its holdings in Beyond Air by 65.0% in the first quarter. Kingdon Capital Management L.L.C. now owns 936,683 shares of the company’s stock worth $255,000 after acquiring an additional 369,157 shares in the last quarter. Wealthedge Investment Advisors LLC boosted its holdings in Beyond Air by 230.0% in the first quarter. Wealthedge Investment Advisors LLC now owns 732,934 shares of the company’s stock worth $200,000 after acquiring an additional 510,807 shares in the last quarter. Finally, Geode Capital Management LLC boosted its holdings in Beyond Air by 81.0% in the fourth quarter. Geode Capital Management LLC now owns 562,713 shares of the company’s stock worth $202,000 after acquiring an additional 251,823 shares in the last quarter. 31.50% of the stock is owned by hedge funds and other institutional investors.

Beyond Air Company Profile

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.